Liraglutide suppresses non-esterified free fatty acids and soluble vascular cell adhesion molecule-1 compared with metformin in patients with recent-onset type 2 diabetes.
about
Liraglutide suppresses non-esterified free fatty acids and soluble vascular cell adhesion molecule-1 compared with metformin in patients with recent-onset type 2 diabetes.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh
2018年學術文章
@zh-hant
name
Liraglutide suppresses non-est ...... recent-onset type 2 diabetes.
@en
Liraglutide suppresses non-est ...... recent-onset type 2 diabetes.
@nl
type
label
Liraglutide suppresses non-est ...... recent-onset type 2 diabetes.
@en
Liraglutide suppresses non-est ...... recent-onset type 2 diabetes.
@nl
prefLabel
Liraglutide suppresses non-est ...... recent-onset type 2 diabetes.
@en
Liraglutide suppresses non-est ...... recent-onset type 2 diabetes.
@nl
P2093
P2860
P1476
Liraglutide suppresses non-est ...... recent-onset type 2 diabetes.
@en
P2093
Chan-Chan Chen
Chuan-Mei Qiu
Li-Fen Wang
Wen-Qiang Zhang
P2860
P2888
P356
10.1186/S12933-018-0701-4
P407
P577
2018-04-10T00:00:00Z
P6179
1103148867